Producer of plant/botanical formulated drugs including, LoChol(tm), a cholesterol reducing product, ACA for the immunological treatment of CFS (Chronic Fatigue Syndrome) and HIV and AIDS patients. The company is in clinical trials to test an immuno building AIDS product, ABAVCA(tm). Also a developer of Sinusol, a natural allergy and sinus spray. Products are sold to the pharmaceutical and biological industries. The bulk of revenue is derived from activity in the biotechnology industry. This company was capitalized by venture capital. Stock symbol: APPI. International sales but percent of sales unknown. Products include natural allergy and sinus spray - Sinusol, hIV and AIDS plant/herbal immunological treatment products, cholesterol reducing products - LoChol(tm).